Clinical trial
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost…
NCT00004786 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004786 |
|---|---|
| Title | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | University of Pittsburgh |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Sclerosis, Raynaud Disease |
| Intervention type | Drug |
| Interventions | iloprost |
| Enrollment | 200 |
| Start date | Dec 1, 1995 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: